Publications by Zausig, York

Mustroph, Julian, Drzymalski, Marzena, Baier, Maria, Pabel, Steffen, Biedermann, Alexander, Memmel, Bernadette, Durczok, Melanie, Neef, Stefan, Sag, Can Martin, Floerchinger, Bernhard, Rupprecht, Leopold, Schmid, Christof, Zausig, York, Bégis, Guillaume, Briand, Veronique, Ozoux, Marie‐Laure, Tamarelle, Dorothee, Ballet, Veronique, Janiak, Philip, Beauverger, Philippe, Maier, Lars S. and Wagner, Stefan (2020) The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure. ESC Heart Failure 7 (5), pp. 2871-2883.

Mustroph, Julian, Wagemann, Olivia, Lücht, Charlotte M., Trum, Maximilian, Hammer, Karin P., Sag, Can Martin, Lebek, Simon, Tarnowski, Daniel, Reinders, Jörg, Perbellini, Filippo, Terracciano, Cesare, Schmid, Christof, Schopka, Simon, Hilker, Michael, Zausig, York, Pabel, Steffen, Sossalla, Samuel T., Schweda, Frank, Maier, Lars S. and Wagner, Stefan (2018) Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes. ESC Heart Failure 5 (4), pp. 642-648.

Floerchinger, Bernhard, Philipp, Alois, Camboni, Daniele, Foltan, Maik, Lunz, Dirk, Lubnow, Matthias, Zausig, York and Schmid, Christof (2017) NSE serum levels in extracorporeal life support patients—Relevance for neurological outcome? Resuscitation 121, pp. 166-171. Fulltext not available.

Lehle, Karla, Lubnow, Matthias, Philipp, Alois, Foltan, Maik, Zeman, Florian, Zausig, York, Lunz, Dirk, Schmid, Christof and Müller, Thomas (2017) Prevalence of hemolysis and metabolic acidosis in patients with circulatory failure supported with extracorporeal life support: a marker for survival? European Journal of Heart Failure 19, pp. 110-116. Fulltext not available.